Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00558519 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

318

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: mercaptopurine
DRUG: methotrexate
DRUG: pegaspargase
DRUG: thioguanine
DRUG: vincristine sulfate
RADIATION: radiation therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]